[ET Net News Agency, 19 March 2018] Grand Brilliance Group Holdings (08372), a medical
device distributor, said it plans to offer 168 million offer shares under the share offer,
of which 16.8 million are public offer shares (subject to reallocation), representing 10%
of the total number of offer shares under the share offer, and 151.2 million are placing
shares, representing 90% of the total number of offer shares.
The offer price ranges between HK$0.30 and HK$0.35 per share, raising up to HK$58.8
million.
The public offer started today, and will close at noon on 22 March. The final offer
price and the results of the allocation are expected to be announced on 28 March. Dealing
in the shares on GEM of the stock exchange will begin on 29 March.
Assuming the offer price of HK$0.325 per offer share, being the mid-point of the offer
price range, the estimated net proceeds will be HK$33.1 million after deducting the
related underwriting commission and expenses payable in relation to the share offer.
The sole sponsor of the proposed listing is Guotai Junan Capital, the sole global
coordinator is Guotai Junan Securities (Hong Kong); the joint bookrunners and the joint
lead managers are Guotai Junan Securities (Hong Kong) and Ruibang Securities. (KL)